Company intelligence / Profile preview

Protean

Dobra Voda u Českých Budějovic, Czech Republic

Ownership: Private
Development stage: Other

Overview

Protean is a commercial ISO 9001 and ISO 13485 certified biotechnology CRO and producer of recombinant proteins, enzymes, antigens, antibodies, cytokines and LAMP/RT‑LAMP diagnostic kits (including CE‑IVD SARS‑CoV‑2 assays) for use in research, IVD diagnostics, and as components in GMP downstream processes for therapeutics and vaccines[1][6][8].

Therapeutic areas: Infectious Diseases
Modalities: ProteinRecombinant proteinEnzymeAntibodyCytokineDiagnostic reagentVaccine component
Industry: Contract Research Organization

Partnerships

Supplies recombinant proteins, enzymes and antigens used by pharmaceutical, biotech and diagnostics companies including Roche and PerkinElmer as referenced customers[1].

Beyond the preview

Go deeper on Protean.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protean.

Explore the full profile